| 0.6 |
1.9 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.4 |
2.1 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.4 |
1.5 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.3 |
1.0 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.3 |
4.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.3 |
1.3 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.3 |
0.9 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 |
0.8 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.3 |
1.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.3 |
1.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
1.8 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 |
0.7 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.2 |
1.3 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
0.7 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.2 |
1.0 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
0.6 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.2 |
2.6 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.2 |
0.5 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 |
0.9 |
GO:1902309 |
positive regulation of mast cell chemotaxis(GO:0060754) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.2 |
0.5 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.2 |
0.5 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 0.2 |
1.1 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.2 |
0.5 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 |
0.9 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.2 |
0.6 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.2 |
0.3 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 0.2 |
0.5 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.2 |
1.1 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.2 |
0.9 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.1 |
0.6 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.4 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
0.4 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.1 |
0.4 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.1 |
1.1 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
0.7 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.1 |
1.3 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.1 |
0.6 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.5 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.7 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.1 |
0.6 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 |
0.7 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.3 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.1 |
0.4 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.1 |
0.4 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
0.5 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.3 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.1 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.1 |
1.2 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.4 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.1 |
0.4 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.1 |
0.3 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.1 |
0.3 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.1 |
1.3 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
1.3 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.4 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.1 |
0.3 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.1 |
0.2 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.1 |
1.2 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.3 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
0.5 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
1.6 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.4 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.8 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.1 |
0.5 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.1 |
0.3 |
GO:0002741 |
positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.1 |
0.7 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.1 |
0.3 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.1 |
0.3 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.5 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.3 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.3 |
GO:1903416 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) response to glycoside(GO:1903416) |
| 0.1 |
0.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.1 |
0.7 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.1 |
1.2 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.4 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 |
0.4 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.1 |
0.3 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.1 |
0.6 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.4 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.1 |
0.2 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 |
0.2 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.2 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.1 |
0.8 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.5 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.2 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.3 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.3 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.6 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.1 |
0.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.3 |
GO:0051057 |
positive regulation of Ras protein signal transduction(GO:0046579) positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.1 |
0.3 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.5 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
0.4 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
0.7 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.1 |
2.1 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.1 |
0.2 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.2 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.1 |
0.3 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.1 |
0.8 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.4 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.2 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.0 |
0.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.3 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.0 |
0.1 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.0 |
0.3 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
0.5 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.0 |
1.2 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.0 |
0.1 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.4 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.0 |
0.2 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 |
0.6 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.4 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.0 |
0.5 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.0 |
0.6 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 |
0.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.1 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.0 |
0.2 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.1 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.0 |
0.3 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.0 |
0.2 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 |
0.4 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 |
0.1 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.0 |
0.2 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.0 |
0.3 |
GO:0098656 |
anion transmembrane transport(GO:0098656) |
| 0.0 |
0.1 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil activation(GO:1902566) |
| 0.0 |
0.1 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.0 |
0.6 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.7 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.7 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.3 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.0 |
0.2 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.0 |
0.4 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 |
0.2 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.3 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 |
0.4 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.8 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.5 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
0.2 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.0 |
0.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.2 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.2 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.0 |
0.1 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.0 |
1.1 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.9 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 |
0.1 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.0 |
0.4 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.1 |
GO:0072592 |
oxygen metabolic process(GO:0072592) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.0 |
0.2 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.0 |
0.3 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.1 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.0 |
0.2 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 |
0.8 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.0 |
0.1 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.0 |
0.4 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.0 |
0.2 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
1.8 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.5 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 |
0.2 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.0 |
1.0 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.0 |
0.1 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.0 |
0.1 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.5 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
0.3 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.3 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.3 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.6 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.0 |
0.2 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.1 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.0 |
0.1 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.0 |
0.1 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.3 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.1 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.0 |
0.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.0 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.0 |
0.4 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.1 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.0 |
0.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 0.0 |
0.1 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.4 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.0 |
0.1 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.0 |
0.0 |
GO:0046985 |
histone H4-R3 methylation(GO:0043985) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.0 |
0.1 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.3 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.0 |
0.0 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 |
0.2 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.0 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.0 |
0.7 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.0 |
0.5 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 |
0.1 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.1 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.1 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.1 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.0 |
0.2 |
GO:0042759 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.0 |
0.2 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.1 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 |
0.3 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 |
0.3 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.2 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.5 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.0 |
0.3 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
| 0.0 |
0.1 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
